These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 26615003)

  • 21. A proposal for management of rheumatic disease patients with hepatitis B virus infection receiving immunosuppressive therapy.
    Harigai M; Mochida S; Mimura T; Koike T; Miyasaka N
    Mod Rheumatol; 2014 Jan; 24(1):1-7. PubMed ID: 24261752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of determination of hepatitis B virus subgenotype and pre-core/core-promoter mutation for the prediction of acute exacerbation of asymptomatic carriers.
    Ikegami T; Matsuki Y; Tanaka Y; Mizokami M; Honda A; Hirayama T; Saito Y; Matsuzaki Y
    Hepatol Res; 2009 Apr; 39(4):341-5. PubMed ID: 19054150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Reactivation of Hepatitis B Virus and Guidelines for Its Prevention].
    Tsubouchi H
    Rinsho Byori; 2015 Sep; 63(9):1046-51. PubMed ID: 26731892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk stratification and clinical course of hepatitis B virus reactivation in rheumatoid arthritis patients with resolved infection: final report of a multicenter prospective observational study at Japanese Red Cross Hospital.
    Fukuda W; Hanyu T; Katayama M; Mizuki S; Okada A; Miyata M; Handa Y; Hayashi M; Koyama Y; Arii K; Kitaori T; Hagiyama H; Urushidani Y; Yamasaki T; Ikeno Y; Suzuki T; Omoto A; Sugitani T; Morita S; Inokuma S
    Arthritis Res Ther; 2019 Nov; 21(1):255. PubMed ID: 31779676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B virus reactivation in patients with rheumatoid arthritis: A single-center study.
    Matsuzaki T; Eguchi K; Nagao N; Tsuji S; Aramaki T; Terada K; Iwatsu S; Tokimura I; Kamo Y; Oda H; Kinoshita N; Miyaaki H; Taura N; Ichikawa T; Kawakami A; Nakao K; Ueki Y
    Mod Rheumatol; 2018 Sep; 28(5):808-813. PubMed ID: 29256314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. China's efforts to shed its title of "Leader in liver disease".
    Li X; Xu WF
    Drug Discov Ther; 2007 Oct; 1(2):84-5. PubMed ID: 22504391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Reactivation of chronic hepatitis B].
    Šperl J
    Vnitr Lek; 2013 Jul; 59(7):591-6. PubMed ID: 23909265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B virus reactivation in patients undergoing cytotoxic chemotherapy for solid tumours: precore/core mutations may play an important role.
    Steinberg JL; Yeo W; Zhong S; Chan JY; Tam JS; Chan PK; Leung NW; Johnson PJ
    J Med Virol; 2000 Mar; 60(3):249-55. PubMed ID: 10630955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Fulminant hepatic failure with hepatitis B virus reactivation after rituximab treatment in a patient with resolved hepatitis B].
    Chung SM; Sohn JH; Kim TY; Yoo KD; Ahn YW; Bae JH; Jeon YC; Choi JH
    Korean J Gastroenterol; 2010 Apr; 55(4):266-9. PubMed ID: 20389182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of hepatitis B virus reactivation in patients with resolved infection on immunosuppressive therapy for rheumatic disease: a multicentre, prospective, observational study in Japan.
    Fukuda W; Hanyu T; Katayama M; Mizuki S; Okada A; Miyata M; Handa Y; Hayashi M; Koyama Y; Arii K; Kitaori T; Hagiyama H; Urushidani Y; Yamasaki T; Ikeno Y; Suzuki T; Omoto A; Sugitani T; Morita S; Inokuma S
    Ann Rheum Dis; 2017 Jun; 76(6):1051-1056. PubMed ID: 27934678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unfavorable prognosis of patients with acute liver injury due to drug-induced liver injury and acute exacerbation of hepatitis B virus infection.
    Kakisaka K; Suzuki Y; Jinnouchi Y; Kanazawa J; Sasaki T; Yonezawa T; Yoshida Y; Kuroda H; Takikawa Y
    Hepatol Res; 2019 Nov; 49(11):1286-1293. PubMed ID: 31251432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression.
    Salpini R; Colagrossi L; Bellocchi MC; Surdo M; Becker C; Alteri C; Aragri M; Ricciardi A; Armenia D; Pollicita M; Di Santo F; Carioti L; Louzoun Y; Mastroianni CM; Lichtner M; Paoloni M; Esposito M; D'Amore C; Marrone A; Marignani M; Sarrecchia C; Sarmati L; Andreoni M; Angelico M; Verheyen J; Perno CF; Svicher V
    Hepatology; 2015 Mar; 61(3):823-33. PubMed ID: 25418031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. INASL Guidelines on Management of Hepatitis B Virus Infection in Patients receiving Chemotherapy, Biologicals, Immunosupressants, or Corticosteroids.
    Arora A; Anand AC; Kumar A; Singh SP; Aggarwal R; Dhiman RK; Aggarwal S; Alam S; Bhaumik P; Dixit VK; Goel A; Goswami B; Kumar A; Kumar M; Madan K; Murugan N; Nagral A; Puri AS; Rao PN; Saraf N; Saraswat VA; Sehgal S; Sharma P; Shenoy KT; Wadhawan M;
    J Clin Exp Hepatol; 2018 Dec; 8(4):403-431. PubMed ID: 30568345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B and Hepatitis C Reactivation in the Biologic Era.
    Bojito-Marrero L; Pyrsopoulos N
    J Clin Transl Hepatol; 2014 Dec; 2(4):240-6. PubMed ID: 26355300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NIH consensus development statement on management of hepatitis B.
    Belongia EA; Costa J; Gareen IF; Grem JL; Inadomi JM; Kern ER; McHugh JA; Petersen GM; Rein MF; Sorrell MF; Strader DB; Trotter HT
    NIH Consens State Sci Statements; 2008 Oct 22-24; 25(2):1-29. PubMed ID: 18949020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mortality secondary to fulminant hepatic failure in patients with prior resolution of hepatitis B virus infection in Japan.
    Umemura T; Tanaka E; Kiyosawa K; Kumada H;
    Clin Infect Dis; 2008 Sep; 47(5):e52-6. PubMed ID: 18643758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spontaneous reactivation of chronic hepatitis B infection leading to fulminant hepatic failure. Report of two cases and review of the literature.
    Meyer RA; Duffy MC
    J Clin Gastroenterol; 1993 Oct; 17(3):231-4. PubMed ID: 8228085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B and cancer: A practical guide for the oncologist.
    Bozza C; Cinausero M; Iacono D; Puglisi F
    Crit Rev Oncol Hematol; 2016 Feb; 98():137-46. PubMed ID: 26657667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with hemato-oncological neoplasias treated with chemotherapy.
    Rossi G
    Leuk Lymphoma; 2003 May; 44(5):759-66. PubMed ID: 12802911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of hepatitis B virus reactivation in patients receiving immunosuppressive therapy or chemotherapy.
    Oketani M; Ido A; Uto H; Tsubouchi H
    Hepatol Res; 2012 Jul; 42(7):627-36. PubMed ID: 22686858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.